EMCDDA Home
  • EN
Search

Table TDI-106. New clients entering outpatient treatment by primary drug and age at first use, 2010 or most recent year available

Part (viii) New 'other drugs' outpatient clients by country and by age at first use

Country<1515-1920-2425-2930-3435-3940-4445+Age knownAge not knownTotal
Belgium1121001063844
Bulgaria00000000000
Czech Republic12100000404
Denmark26020020121022
Germany5379158534317056226
Estonia:::::::::::
Ireland14641511201210912121
Greece01000000101
Spain15621614429130
France188252:4::43:
Italy20336602480241559164
Cyprus01000000101
Latvia37240100014721
Lithuania:::::::::::
Luxembourg:::::::::::
Hungary81393311038038
Malta:1:::1:::::
Netherlands713642310365995
Austria11011000013013
Poland46241:2:::1:
Portugal51927189220178684
Romania16744814101001637170
Slovenia1::::::::::
Slovakia00000000000
Finland10010000202
Sweden132074012148048
United Kingdom67997403523915::126:
Croatia4210000::7:
Turkey:::::::::::
Norway:::::::::::
Total256462241100803235358793821084
 

Notes:

: Indicates no data are available

(1) Data are from 2010.

(2) In 2011 around 27% of all clients and 32% of new clients were registered as not known / missing for the primary drug category. Caution should be made when comparing data over time.

(3) In 2010 Latvia submitted a new dataset with a more precise TDI EMCDDA definition. Caution should be made when comparing data with previous years.

(4) Data are from 2010. Data presented in the table come from TDI pilot project. Caution should be made when interpreting the data.

(5) In 2010 came into implementation a new national information system implying methodological changes particularly in the registration criteria. Caution should be made when comparing 2010 data with previous years.

(6) Data are from 1st of April 2010 to 31st March 2011.

For more information relative to the treatment centre type, please see Table TDI-7.

See also Table TDI-11 part(i), part(ii)

‘General notes for interpreting data'’ on the Explanatory notes and help page.

Source:

Reitox national reports 2012- Table TDI Outpatient Treatment Centres

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Friday, 26 April 2013